| Literature DB >> 25844054 |
Maria-Belen Gonzalez-Sanchez1, Francesco Lanucara2, Gemma E Hardman3, Claire E Eyers2.
Abstract
The hydrogen bonds and electrostatic interactions that form between the protonated side chain of a basic residue and the negatively charged phosphate of a phosphopeptide can play crucial roles in governing their dissociation pathways under low-energy collision-induced dissociation (CID). Understanding how phosphoramidate (i.e. phosphohistidine, phospholysine and phosphoarginine), rather than phosphomonoester-containing peptides behave during CID is paramount in investigation of these problematic species by tandem mass spectrometry. To this end, a synthetic peptide containing either phosphohistidine (pHis) or phospholysine (pLys) was analyzed by ESI-MS using a Paul-type ion trap (AmaZon, Bruker) and by traveling wave ion mobility-mass spectrometry (Synapt G2-Si, Waters). Analysis of the products of low-energy CID demonstrated formation of a doubly 'phosphorylated' product ion arising from intermolecular gas-phase phosphate transfer within a phosphopeptide dimer. The results are explained by the formation of a homodimeric phosphohistidine (pHis) peptide non-covalent complex (NCX), likely stabilized by the electrostatic interaction between the pHis phosphate group and the protonated C-terminal lysine residue of the peptide. To the best of our knowledge this is the first report of intermolecular gas-phase phosphate transfer from one phosphopeptide to another, leading to a doubly phosphorylated peptide product ion.Entities:
Keywords: CID; Gas-phase dimer; Histidine phosphorylation; NCX, non-covalent complex; Non-covalent interactions; Phosphoramidate; Phosphotransfer; TWIMS, travelling wave ion mobility-mass spectrometry; pArg, phosphoarginine; pHis, phosphohistidine; pLys, phospholysine
Year: 2014 PMID: 25844054 PMCID: PMC4375673 DOI: 10.1016/j.ijms.2014.04.015
Source DB: PubMed Journal: Int J Mass Spectrom ISSN: 1387-3806 Impact factor: 1.986
Fig. 1ESI-ion trap full scan mass spectrum of the products of the reaction between peptide FVIAFILHLVK and potassium phosphoramidate (KNH2PO3H2). Inset shows an enhanced region of the mass spectrum encompassing m/z range 1280–1400.
Fig. 2CID product ion mass spectrum of the doubly charged ion of the phosphorylated peptide p[FVIAFILHLVK+2H]2+ at m/z 690.5, indicating a heterogeneous population of [FVIAFILpHLVK+2H]2+ and [FVIAFILHLVpK+2H]2+, whose specific y-ions are labeled in italics (gray). (Δ) Loss of 80 Da (HPO3); (*) Observation of both phosphorylated and non-phosphorylated product ions.
Fig. 3CID product ion mass spectrum of the singly charged ion of the phosphorylated peptide [p(FVIAFILHLVK)+H]+ at m/z 1379.5. (Δ) Loss of 80 Da (HPO3).
Fig. 4Traveling wave ion mobility-mass spectrometry analysis of the ions at m/z 1379.5 demonstrating a mixed population of singly protonated phosphopeptide monomer [M+H]+ and doubly protonated dimer [M2+2H]2+. (A) Isotopic distribution and (B) arrival time distribution (ATD) of the mixed population. Inset (A) depicts the theoretical isotope distribution (assuming 1:1 stoichiometry) of the [M+H]+ and [M2+2H]2+. Extracted ion current for the (C) longer (red) and (D) shorter (blue) ATDs (E) indicating mobility separation of the monomeric and dimeric populations.
Fig. 5MS3 CID product ion mass spectrum of ions at m/z 1459.4 generated by CID of ions at m/z 1379.5. The doubly ‘phosphorylated’ peptide is represented by p(FVIAFILpHLVK). (Δ) Loss of 80 Da (HPO3).
Scheme 1Proposed mechanism for the formation of the ions at m/z 1459.8. The scheme depicts a homodimer of the phosphopeptide FVIAFILpHLVK (m/z 1379.8), whose components can undergo elimination of metaphosphoric acid HPO3 and generation of a transient ternary complex, which then evolves to give the dephosphorylated peptide at m/z 1299.8 and the ‘doubly’ phosphorylated peptide at m/z 1459.8.